Last reviewed · How we verify

2.5% or 10% phenylephrine

Khon Kaen University · FDA-approved active Small molecule Quality 5/100

2.5% or 10% phenylephrine is a Small molecule drug developed by Khon Kaen University. It is currently FDA-approved.

At a glance

Generic name2.5% or 10% phenylephrine
SponsorKhon Kaen University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 2.5% or 10% phenylephrine

What is 2.5% or 10% phenylephrine?

2.5% or 10% phenylephrine is a Small molecule drug developed by Khon Kaen University.

Who makes 2.5% or 10% phenylephrine?

2.5% or 10% phenylephrine is developed and marketed by Khon Kaen University (see full Khon Kaen University pipeline at /company/khon-kaen-university).

What development phase is 2.5% or 10% phenylephrine in?

2.5% or 10% phenylephrine is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing